title: Quinine for muscle cramps.
abstract: BACKGROUND
  Muscle cramps can occur anywhere and for many reasons. Quinine has been used to treat cramps of all causes. However, controversy continues about its efficacy and safety. This review was first published in 2010 and searches were updated in 2014.
  
  
  OBJECTIVE
  To assess the efficacy and safety of quinine-based agents in treating muscle cramps.
  
  
  METHODS
  On 27 October 2014 we searched the Cochrane Neuromuscular Disease Group Specialized Register, CENTRAL, MEDLINE and EMBASE. We searched reference lists of articles up to 2014. We also searched for ongoing trials in November 2014.
  
  
  METHODS
  Randomised controlled trials of people of all ages with muscle cramps in any location and of any cause, treated with quinine or its derivatives.
  
  
  METHODS
  Three review authors independently selected trials for inclusion, assessed risk of bias and extracted data. We contacted study authors for additional information. For comparisons including more than one trial, we assessed the quality of the evidence using Grading of Recommendations Assessment, Development and Evaluation (GRADE).
  
  
  RESULTS
  We identified 23 trials with a total of 1586 participants. Fifty-eight per cent of these participants were from five unpublished studies. Quinine was compared to placebo (20 trials, n = 1140), vitamin E (four trials, n = 543), a quinine-vitamin E combination (three trials, n = 510), a quinine-theophylline combination (one trial, n = 77), and xylocaine injections into the gastrocnemius muscle (one trial, n = 24). The most commonly used quinine dosage was 300 mg/day (range 200 to 500 mg). We found no new trials for inclusion when searches were updated in 2014.The risk of bias in the trials varied considerably. All 23 trials claimed to be randomised, but only a minority described randomisation and allocation concealment adequately.Compared to placebo, quinine significantly reduced cramp number over two weeks by 28%, cramp intensity by 10%, and cramp days by 20%. Cramp duration was not significantly affected.A significantly greater number of people suffered minor adverse events on quinine than placebo (risk difference (RD) 3%, 95% confidence interval (CI) 0% to 6%), mainly gastrointestinal symptoms. Overdoses of quinine have been reported elsewhere to cause potentially fatal adverse effects, but in the included trials there was no significant difference in major adverse events compared with placebo (RD 0%, 95% CI -1% to 2%). One participant suffered from thrombocytopenia (0.12% risk) on quinine.A quinine-vitamin E combination, vitamin E alone, and xylocaine injections into gastrocnemius were not significantly different to quinine across all outcomes, including adverse effects. Based on a single trial comparison, quinine alone was significantly less effective than a quinine-theophylline combination but with no significant differences in adverse events.
  
  
  CONCLUSIONS
  There is low quality evidence that quinine (200 mg to 500 mg daily) significantly reduces cramp number and cramp days and moderate quality evidence that quinine reduces cramp intensity. There is moderate quality evidence that with use up to 60 days, the incidence of serious adverse events is not significantly greater than for placebo in the identified trials, but because serious adverse events can be rarely fatal, in some countries prescription of quinine is severely restricted.Evidence from single trials suggests that theophylline combined with quinine improves cramps more than quinine alone, and the effects of xylocaine injections into gastrocnemius are not significantly different to quinine across all outcomes. Low or moderate quality evidence shows no significant difference between quinine and vitamin E or quinine and quinine-vitamin E mixture. Further research into these alternatives, as well other pharmacological and non-pharmacological treatments, is thus warranted.There is no evidence to judge optimal dosage or duration of quinine treatment. Further studies using different dosages and measurement of serum quinine levels will allow a therapeutic range to be defined for muscle cramp. Because serious adverse events are not common, large population studies are required to more accurately inform incidence. Longer lengths of follow-up in future trials will help determine the duration of action following cessation of quinine as well as long-term adverse events. The search for new therapies, pharmacological and nonpharmacological, should continue and further trials should compare vitamin E, quinine-vitamin E combination, and quinine-theophylline mixture with quinine.
authors.affiliation: Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Diseases, PO Box 114, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK, WC1N 3BG.
authors.forename: Sherif
authors.initials: S
authors.lastname: El-Tawil
authors.forename: Tarique
authors.initials: T
authors.lastname: Al Musa
authors.forename: Haseeb
authors.initials: H
authors.lastname: Valli
authors.forename: Michael P T
authors.initials: MP
authors.lastname: Lunn
authors.forename: Ruth
authors.initials: R
authors.lastname: Brassington
authors.forename: Tariq
authors.initials: T
authors.lastname: El-Tawil
authors.forename: Markus
authors.initials: M
authors.lastname: Weber
mesh_terms: D004359:Drug Therapy, Combination; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D009120:Muscle Cramp / Q000188:drug therapy*; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000627:therapeutic use*; D011803:Quinine / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013806:Theophylline / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D009125:Muscle Relaxants, Central; D014815:Vitamins; D014810:Vitamin E; D008012:Lidocaine; D011803:Quinine; D013806:Theophylline
references.citation: South Med J. 1974 Nov;67(11):1308-12
references.pmid: 4428211
references.citation: Am J Med Sci. 1997 Apr;313(4):210-4
references.pmid: 9099150
references.citation: Med Sci Monit. 2002 May;8(5):CR326-30
references.pmid: 12011773
references.citation: Neurology. 2010 Feb 23;74(8):691-6
references.pmid: 20177124
references.citation: Trans R Soc Trop Med Hyg. 2002 Mar-Apr;96(2):180-4
references.pmid: 12055810
references.citation: Postgrad Med. 1989 Sep 1;86(3):227-32
references.pmid: 2671968
references.citation: Q J Med. 1985 Feb;54(214):125-31
references.pmid: 3983356
references.citation: Br J Clin Pract. 1986 Nov;40(11):462
references.pmid: 3307858
references.citation: Clin Pharmacokinet. 1996 Apr;30(4):263-99
references.pmid: 8983859
references.citation: Age Ageing. 1983 May;12(2):155-8
references.pmid: 6346830
references.citation: Eur Arch Psychiatry Neurol Sci. 1990;239(5):337-42
references.pmid: 2140785
references.citation: Clin Pharmacol Ther. 1975 Dec;18(6):670-9
references.pmid: 1204275
references.citation: Muscle Nerve. 2005 Oct;32(4):431-42
references.pmid: 15902691
references.citation: J Clin Pharmacol. 1995 Jun;35(6):588-93
references.pmid: 7665718
references.citation: Pediatrics. 2001 Sep;108(3):776-89
references.pmid: 11533352
references.citation: Drug Saf. 1996 Mar;14(3):131-45
references.pmid: 8934576
references.citation: Ann Intern Med. 1993 Aug 1;119(3):215-7
references.pmid: 8323089
references.citation: Int J Clin Pract. 2002 May;56(4):243-6
references.pmid: 12074203
references.citation: J Gen Intern Med. 1998 Sep;13(9):600-6
references.pmid: 9754515
references.citation: BMJ. 1990 Aug 11;301(6747):323
references.pmid: 2393740
references.citation: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004912
references.pmid: 18843672
references.citation: Acta Med Scand. 1985;218(2):229-32
references.pmid: 4061126
references.citation: Muscle Nerve. 1994 Nov;17(11):1243-9
references.pmid: 7935546
references.citation: Hepatology. 1996 Feb;23(2):264-73
references.pmid: 8591851
references.citation: Lancet Infect Dis. 2007 Aug;7(8):549-58
references.pmid: 17646028
references.citation: Arch Intern Med. 1988 Sep;148(9):1969-70
references.pmid: 3046538
references.citation: J Am Geriatr Soc. 1993 May;41(5):498-500
references.pmid: 8486881
references.citation: Calif Med. 1969 Aug;111(2):87-91
references.pmid: 5346435
references.citation: J Physiother. 2012;58(1):17-22
references.pmid: 22341378
references.citation: Med Klin. 1980 Mar 28;75(7):264-7
references.pmid: 6993901
references.citation: Arch Intern Med. 1990 Mar;150(3):511-8
references.pmid: 2178579
references.citation: Br J Gen Pract. 1993 Mar;43(368):127-8
references.pmid: 8323792
references.citation: J Hepatol. 1991 Mar;12(2):236-40
references.pmid: 2051002
references.citation: Lancet. 1976 Jul 10;2(7976):66-7
references.pmid: 59150
references.citation: Intensive Care Med. 2003 Jun;29(6):1007-1011
references.pmid: 12682720
references.citation: Am J Gastroenterol. 1996 Jul;91(7):1363-6
references.pmid: 8677996
references.citation: Br J Gen Pract. 2005 Mar;55(512):186-91
references.pmid: 15808033
references.citation: Can J Ophthalmol. 1966 Oct;1(4):261-6
references.pmid: 5977436
references.citation: Cochrane Database Syst Rev. 2002;(1):CD000121
references.pmid: 11869565
references.citation: Blood. 1993 Nov 1;82(9):2714-8
references.pmid: 8219224
references.citation: Br J Clin Pharmacol. 1987 Apr;23(4):459-65
references.pmid: 3555580
references.citation: Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):651-6
references.pmid: 11816439
references.citation: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009402
references.pmid: 22972143
references.citation: Practitioner. 1990 Apr 22;234(1487):420-1
references.pmid: 2367299
references.citation: J Med Assoc Thai. 1999 May;82(5):451-9
references.pmid: 10443094
references.citation: Br J Gen Pract. 2005 Mar;55(512):181-5
references.pmid: 15808032
references.citation: BMJ. 1995 Dec 9;311(7019):1541
references.pmid: 8520397
references.citation: West J Med. 1989 Jul;151(1):42-4
references.pmid: 2669346
references.citation: BMJ. 1995 Jan 7;310(6971):13-7
references.pmid: 7827545
references.citation: Cochrane Database Syst Rev. 2010 Dec 08;(12):CD005044
references.pmid: 21154358
references.citation: Med J Aust. 2002 Apr 1;176(7):351
references.pmid: 12013332
references.citation: Brain. 1994 Oct;117 ( Pt 5):929-39
references.pmid: 7953602
references.citation: Cochrane Database Syst Rev. 2012 Jan 18;1:CD008496
references.pmid: 22258986
references.citation: Consult Pharm. 2008 Feb;23(2):141-56
references.pmid: 18454580
references.citation: Arzneimittelforschung. 1991 Feb;41(2):167-75
references.pmid: 2043179
references.citation: Ann Intern Med. 2005 Jan 4;142(1):37-46
references.pmid: 15537682
references.citation: Postgrad Med J. 2002 Oct;78(924):596-8
references.pmid: 12415081
references.citation: Lancet Infect Dis. 2010 Nov;10(11):762-9
references.pmid: 20932805
references.citation: Eur J Emerg Med. 2003 Dec;10(4):353-6
references.pmid: 14676522
references.citation: Age Ageing. 1994 Sep;23(5):418-20
references.pmid: 7825490
references.citation: Int J Clin Pract. 1999 Oct-Nov;53(7):494-6
references.pmid: 10692732
references.citation: Lancet. 1997 Feb 22;349(9051):528-32
references.pmid: 9048790
references.citation: Nephrol Dial Transplant. 2001 Jul;16(7):1448-51
references.pmid: 11427639
references.citation: Curr Drug Saf. 2006 Jan;1(1):1-15
references.pmid: 18690910
references.citation: Clin Nephrol. 1997 Jun;47(6):397-400
references.pmid: 9202872
references.citation: J Neurol Sci. 1994 Apr;122(2):157-61
references.pmid: 8021700
references.citation: Arch Intern Med. 1992 Sep;152(9):1877-80
references.pmid: 1520054
references.citation: ASAIO J. 1992 Jul-Sep;38(3):M481-5
references.pmid: 1457907
references.citation: Med Clin (Barc). 1980 Oct 10;75(6):247-9
references.pmid: 7421359
references.citation: Postgrad Med J. 1993 Aug;69(814):624-6
references.pmid: 8234106
references.citation: Am J Obstet Gynecol. 1995 Jul;173(1):175-80
references.pmid: 7631676
references.citation: J Rheumatol. 1985 Dec;12(6):1149-53
references.pmid: 4093922
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120
references.citation: Br J Clin Pharmacol. 2003 Nov;56(5):576-8
references.pmid: 14651733
references.citation: Acta Otolaryngol Suppl. 1971;291:1-27
references.pmid: 4340007